4 research outputs found
Acceptability and perception of the herpes zoster vaccine in the 65 and over population: A French observational study
International audienceLâobjectif de lâĂ©tude Ă©tait dâĂ©valuer lâacceptabilitĂ© et de dĂ©crire la perception de la vaccination contre lâherpĂšs zoster (HZ) chez les patients ambulatoires et hospitalisĂ©s Ă Lyon, en France, ĂągĂ©s de 65 ans et plus. Une Ă©tude observationnelle Ă©tait basĂ©e sur un questionnaire rempli lors dâune entrevue en personne de janvier 2018 Ă mars 2019. Les patients externes bĂ©nĂ©voles qui ont frĂ©quentĂ© des laboratoires mĂ©dicaux privĂ©s ou qui ont Ă©tĂ© hospitalisĂ©s dans le service de gĂ©riatrie, ou qui Ă©taient Ă la clinique mĂ©dicale ambulatoire pour une consultation ont Ă©tĂ© invitĂ©s Ă participer. Au total, 907 personnes ont Ă©tĂ© interrogĂ©es, avec un Ăąge moyen de 75,8 ans. Une grande majoritĂ© de 87,6 % (795) connaissaient le ZONA et 68,9 % (625) accepteraient dâĂȘtre vaccinĂ©s contre lâAS Sâils prĂ©sentaient des facteurs de risque. Les participants connaissaient le HZ en tant que maladie, mais la sensibilisation au vaccin fait encore dĂ©faut dans le grand public
Anaerobe
INTRODUCTION: The magnitude and scope of Clostridioides difficile infection (CDI) has changed with an increase in incidence and severity. The epidemiology of CDI is not well known in France due to difficulties to conduct large continuous surveillance. The objectives were to compare the characteristics of patients with CDI collected through repeated point prevalence survey via DIFTECâą, a free electronic tool, with those from previous French or European studies. METHODS: DIFTECâą was developed to evaluate epidemiological burden, diagnostic strategies and management of CDI in France. National and European guidelines were used for definitions. A literature review of studies conducted in Western Europe on CDI and published between January, 2008 and May, 2018 was done to compare their data with those included in the DIFTECâą database. RESULTS: From January 2016, to December 2017, 455 CDI episodes from 22 French hospitals were included. Most of CDI cases were health-care associated (HCA) (78%). The comparison between included patients and French literature data showed that the rates of previous antibiotics exposure, crude mortality and recurrence were not statistically different. However HCA-CDI was significantly more frequent in the DIFTECâą study. Gender distribution, recurrence and crude mortality rates were not statistically different compared to European data. HCA-CDI was more frequent in the DIFTECâą study whereas previous treatment with proton pump inhibitors and antibiotics were significantly higher in European studies. DISCUSSION: These results illustrated the added value of a new tool for increasing the reliable knowledge of CDI in France based on epidemiological surveillance implemented in health-care settings
: Anaerobe
International audienceINTRODUCTION: The magnitude and scope of Clostridioides difficile infection (CDI) has changed with an increase in incidence and severity. The epidemiology of CDI is not well known in France due to difficulties to conduct large continuous surveillance. The objectives were to compare the characteristics of patients with CDI collected through repeated point prevalence survey via DIFTECâą, a free electronic tool, with those from previous French or European studies. METHODS: DIFTECâą was developed to evaluate epidemiological burden, diagnostic strategies and management of CDI in France. National and European guidelines were used for definitions. A literature review of studies conducted in Western Europe on CDI and published between January, 2008 and May, 2018 was done to compare their data with those included in the DIFTECâą database. RESULTS: From January 2016, to December 2017, 455 CDI episodes from 22 French hospitals were included. Most of CDI cases were health-care associated (HCA) (78%). The comparison between included patients and French literature data showed that the rates of previous antibiotics exposure, crude mortality and recurrence were not statistically different. However HCA-CDI was significantly more frequent in the DIFTECâą study. Gender distribution, recurrence and crude mortality rates were not statistically different compared to European data. HCA-CDI was more frequent in the DIFTECâą study whereas previous treatment with proton pump inhibitors and antibiotics were significantly higher in European studies. DISCUSSION: These results illustrated the added value of a new tool for increasing the reliable knowledge of CDI in France based on epidemiological surveillance implemented in health-care settings
: Anaerobe
International audienceINTRODUCTION: The magnitude and scope of Clostridioides difficile infection (CDI) has changed with an increase in incidence and severity. The epidemiology of CDI is not well known in France due to difficulties to conduct large continuous surveillance. The objectives were to compare the characteristics of patients with CDI collected through repeated point prevalence survey via DIFTECâą, a free electronic tool, with those from previous French or European studies. METHODS: DIFTECâą was developed to evaluate epidemiological burden, diagnostic strategies and management of CDI in France. National and European guidelines were used for definitions. A literature review of studies conducted in Western Europe on CDI and published between January, 2008 and May, 2018 was done to compare their data with those included in the DIFTECâą database. RESULTS: From January 2016, to December 2017, 455 CDI episodes from 22 French hospitals were included. Most of CDI cases were health-care associated (HCA) (78%). The comparison between included patients and French literature data showed that the rates of previous antibiotics exposure, crude mortality and recurrence were not statistically different. However HCA-CDI was significantly more frequent in the DIFTECâą study. Gender distribution, recurrence and crude mortality rates were not statistically different compared to European data. HCA-CDI was more frequent in the DIFTECâą study whereas previous treatment with proton pump inhibitors and antibiotics were significantly higher in European studies. DISCUSSION: These results illustrated the added value of a new tool for increasing the reliable knowledge of CDI in France based on epidemiological surveillance implemented in health-care settings